Neurocrine Biosciences, Inc. (NBIX)
155.64
-2.71
(-1.71%)
USD |
NASDAQ |
Sep 04, 16:00
156.18
+0.54
(+0.35%)
After-Hours: 20:00
Neurocrine Biosciences Cash and Short Term Investments (Annual) : 1.480B for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 1.480B |
| December 31, 2024 | 1.076B |
| December 31, 2023 | 1.032B |
| December 31, 2022 | 989.30M |
| December 31, 2021 | 711.30M |
| December 31, 2020 | 801.00M |
| December 31, 2019 | 670.52M |
| December 31, 2018 | 650.91M |
| December 31, 2017 | 515.93M |
| December 31, 2016 | 307.35M |
| December 31, 2015 | 379.19M |
| December 31, 2014 | 193.81M |
| December 31, 2013 | 145.74M |
| December 31, 2012 | 173.01M |
| December 31, 2011 | 129.10M |
| Date | Value |
|---|---|
| December 31, 2010 | 126.86M |
| December 31, 2009 | 54.76M |
| December 31, 2008 | 80.47M |
| December 31, 2007 | 179.38M |
| December 31, 2006 | 182.60M |
| December 31, 2005 | 273.07M |
| December 31, 2004 | 301.13M |
| December 31, 2003 | 453.17M |
| December 31, 2002 | 244.71M |
| December 31, 2001 | 319.98M |
| December 31, 2000 | 164.67M |
| December 31, 1999 | 91.10M |
| December 31, 1998 | 62.67M |
| December 31, 1997 | 75.09M |
| December 31, 1996 | 69.92M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Amarin Corp. Plc | 302.79M |
| Liquidia Corp. | 190.68M |
| Halozyme Therapeutics, Inc. | 142.82M |
| Iovance Biotherapeutics, Inc. | 296.98M |
| Precigen, Inc. | 97.86M |